"Patent-free" doesn't help much when the hoops to bring "free" drug to market averages over 1bn.
Fediblob Bio-Tech Startup, Inc. never gets to shot 1 in arm 1 at that rate.
And while Uncle Sam is backing up dumptrucks of cash to pharma corpos, where did their billions in regulatory fees go? Or right, to writing infinite new red-tape on Fediblob Bio-Tech Startup, Inc. We never get our foot in the door without a Hunter equivalant on our Board of Directors.